IT'S TIME TO BREAK FREE WITH THE ONLY 6-MONTH* CGM

Manage your diabetes simply and with confidence

GET STARTED

HERE'S HOW EVERSENSE E3 CAN CHANGE YOUR LIFE

Watch to learn how Eversense's up to 6-month, under-the-skin CGM can help you break free and confidently live your life!

COMPONENTS OF THE EVERSENSE CGM SYSTEM

Eversense diabetes CGM system sensor.

Sensor

The sensor is inserted by a trained health care provider in the upper arm and continuously measures glucose for up to 6 months.

View Sensor >
Eversense CGM smart transmitter device.

Smart Transmitter

Worn over the sensor, the transmitter wirelessly sends data to user’s mobile device; is removable** and rechargeable and provides unique on-body vibe alerts.

View Transmitter >
Woman holding a cell phone with Eversense diabetes information.

Mobile Application

Displays and updates real-time glucose readings every 5 minutes with intuitive graphical design to show if you are in or out of range. Remote real-time monitoring capability - up to 5 people.†

View App >
 

THE NEW EVERSENSE E3 CGM SYSTEM

Long-Term Convenience

One sensor continuously for up to 6 months

Peace of Mind Accuracy

Peace of Mind Accuracy

Exceptional accuracy over 6 months, including with hypoglycemia

Flexibility of Wear

Flexibility of Wear

Easy on, easy-off transmitter to fit your lifestyle**

Discreet Alerts

Discreet Alerts

Distinct on-body vibe alerts when high or low

Gentle on skin

Gentle on skin

Silicone-based fresh daily adhesive for comfort (can help reduce skin reactions)

Readings You Can Count On

Readings You Can Count On

Consistent accuracy over 6 months

GET STARTED WITH THE EVERSENSE SYSTEM

 

If you're on multiple daily doses of insulin, you might greatly benefit from Eversense. Complete the form below so we can tell you more about Eversense and check your eligibility and coverage. An Ascensia Diabetes Care representative will be in touch shortly.
*Required Field

 

COVERAGE

Learn more about insurance coverage and eligibility

VIEW COVERAGE
Woman using her phone to research coverage for an implantable CGM.

FAQ

Search our most commonly asked questions for quick answers.

VIEW FAQS
Woman views cell phone to read about Eversense CGM FAQs.

EVERYONE HAS THEIR OWN EVERSENSE STORY

Matt used to always worry about knocking his CGM sensor off. See how Eversense changed all that.

PATIENT STORIES

* Up to 6 months
**There is no glucose data generated when the transmitter is removed
***The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.